These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17785064)

  • 1. [Changes of serum hepatocyte growth factor before and after percutaneous coronary intervention in patients with unstable angina pectoris and significance there].
    Wang NF; Tong GX; Li PZ; Zhang XW; Xu J; Wu GP; Jin JF; Zhou L; Ye XH; Yang JM; Pan H
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1411-3. PubMed ID: 17785064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of short-term high-dose atorvastatin on systemic inflammatory response and myocardial ischemic injury in patients with unstable angina pectoris undergoing percutaneous coronary intervention.
    Sun F; Yin Z; Shi Q; Zhao B; Wang S
    Chin Med J (Engl); 2014; 127(21):3732-7. PubMed ID: 25382328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of early percutaneous coronary intervention in patients with Braunwald III-B type unstable angina pectoris].
    Nozaki K; Nakao K; Horiuchi K; Kasanuki H; Honda T
    J Cardiol; 2003 Jun; 41(6):263-70. PubMed ID: 12845880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris.
    Bertinchant JP; Polge A; Ledermann B; Genet L; Fabbro-Peray P; Raczka F; Brunet J; Poirey S; Wittenberg O; Pernel I; Nigond J
    Am J Cardiol; 1999 Jul; 84(1):51-7. PubMed ID: 10404851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes of serum hepatocyte growth factor in coronary artery disease].
    Suzuki H; Murakami M; Kondo T; Shibata M; Ezumi H; Okabayashi H; Yorozuya M; Makishima N; Hamazaki Y; Nakatani M; Namiki A; Katagiri T
    J Cardiol; 2000 May; 35(5):319-24. PubMed ID: 10834175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of lipid microspheres 1 on myocardial injury following elective percutaneous coronary intervention in patients with angina pectoris: a pilot study.
    Chu-fan L; Xing W; Xun H; Gui-fu W; Cheng-heng H; Zhi-min D
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):790-4. PubMed ID: 21934521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis.
    Saleh N; Tornvall P
    Atherosclerosis; 2007 Dec; 195(2):374-8. PubMed ID: 17126343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of elevated troponin I after percutaneous coronary intervention.
    Cantor WJ; Newby LK; Christenson RH; Tuttle RH; Hasselblad V; Armstrong PW; Moliterno DJ; Califf RM; Topol EJ; Ohman EM;
    J Am Coll Cardiol; 2002 Jun; 39(11):1738-44. PubMed ID: 12039485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of serum hepatocyte growth factor in patients with acute coronary syndromes.
    Sato T; Yoshinouchi T; Sugimoto T; Sakamoto T; Fujieda H; Murao S; Sato H; Ohe T
    Jpn Circ J; 1999 Aug; 63(8):583-8. PubMed ID: 10478806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of percutaneous coronary intervention in unstable angina pectoris versus stable angina pectoris in two different time periods.
    Naidu SS; Polin GM; Selzer F; Laskey WK; Jacobs AK; Williams DO; Wilensky RL
    Am J Cardiol; 2006 Aug; 98(4):447-52. PubMed ID: 16893695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
    Fan Y; Jiang Y; Fu X; Cai J; Wang Y; Li W; Gu X; Xing K; Bai S; Bi X
    Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating CD34⁺ progenitor cells and growth factors in patients treated with PCI for acute myocardial infarction or stable angina pectoris.
    Grøgaard HK; Solheim S; Landsverk KS; Seljeflot I; Hoffmann P; Arnesen H; Ilebekk A
    Scand J Clin Lab Invest; 2011 Jul; 71(4):322-9. PubMed ID: 21463159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor production may be related to the inflammatory response in patients with acute myocardial infarction.
    Shimada Y; Yoshiyama M; Jissho S; Kamimori K; Nakamura Y; Iida H; Takeuchi K; Yoshikawa J
    Circ J; 2002 Mar; 66(3):253-6. PubMed ID: 11922273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac troponin I for risk stratification following percutaneous coronary artery intervention in acute coronary syndromes.
    Nageh T; Sherwood RA; Harris BM; Thomas MR
    Catheter Cardiovasc Interv; 2002 Jan; 55(1):37-42. PubMed ID: 11793493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
    Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
    Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final myocardial blush grade predicts troponin I elevation in unstable angina patients undergoing percutaneous intervention.
    Prasan AM; Flood C; Pitney MR; Walsh W; Jepson NS
    Heart Lung Circ; 2006 Oct; 15(5):291-6. PubMed ID: 16860603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes of circulating endothelial progenitor cells in patients with coronary heart diseases before and after percutaneous coronary intervention].
    Luo YS; Qian JY; Zhang L; Ma JY; Huang D; Fan B; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Feb; 38(2):126-30. PubMed ID: 20398557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina.
    Benamer H; Steg PG; Benessiano J; Vicaut E; Gaultier CJ; Aubry P; Boudvillain O; Sarfati L; Brochet E; Feldman LJ; Himbert D; Juliard JM; Assayag P
    Am Heart J; 1999 May; 137(5):815-20. PubMed ID: 10220629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the antithrombotlic effect and safety between intravenous nadroparin and unfractionated heparin in patients undergoing percutaneous coronary intervention].
    Zhu JH; Qiu YG; Chen JZ; Zhang FR; Fu GS; Shen FR; Huang WJ; Wang JA; Zhao LL; Tao QM; Zheng LR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):335-9. PubMed ID: 15932664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
    Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
    Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.